[#item_full_content] Trulieve Cannabis just received a small uplift in its fair value estimate, shifting from 19.025813 to 19.060341, while the discount rate used in the model remains essentially unchanged at 6.446% and the long term revenue growth assumption stays close to 2.47%. This kind of minor adjustment often reflects analysts fine tuning their models as they weigh cautious and optimistic signals from similar companies rather than rewriting the whole story. Stay tuned to see how you can keep on top of… Read More
PSN Briefings
Plain-English cannabis industry updates — what changed, what didn’t, and why it matters.
Episode 1 • Federal Rescheduling — What Actually ChangedLatest PSN Briefs
Short, plain-English updates from the PSN desk
- What federal rescheduling did NOT change
- Why state cannabis boards still control outcomes
- What operators should not assume in 2026